Invention Grant
- Patent Title: Erk1/2 posphorylation site specific antibody
- Patent Title (中): Erk1 / 2磷酸化位点特异性抗体
-
Application No.: US13130495Application Date: 2009-11-26
-
Publication No.: US08796428B2Publication Date: 2014-08-05
- Inventor: Martin J. Lohse , Kristina Lorenz
- Applicant: Martin J. Lohse , Kristina Lorenz
- Applicant Address: DE Wuerzburg
- Assignee: Julius-Maximilians-Universitaet Wuerzburg
- Current Assignee: Julius-Maximilians-Universitaet Wuerzburg
- Current Assignee Address: DE Wuerzburg
- Agency: Smith, Gambrell & Russell, LLP
- Agent Suzannah K. Sundby, Esq.
- Priority: EP08020518 20081126
- International Application: PCT/EP2009/065935 WO 20091126
- International Announcement: WO2010/060972 WO 20100603
- Main IPC: C07K16/40
- IPC: C07K16/40 ; C07K16/00 ; C12N5/07 ; G01N33/53
Abstract:
The invention relates to an antibody specific to Erk1/2 phosphorylated at Thr188 and a method for producing the same. The invention also relates to an in vitro method for determining the presence of phosphorylated Erk1/2 in a sample using the antibody of the invention. Therefore, the invention also comprises an assay for diagnosing a heart disease in vitro comprising the antibody of the invention and certain uses of the antibody. Moreover the invention relates to a peptide used to produce the antibody.
Public/Granted literature
- US20110274694A1 ERK1/2 Posphorylation Site Specific Antibody Public/Granted day:2011-11-10
Information query
